Brian McCloskey has advanced prostate cancer. He’s been through the standard of care. but his cancer is resisting the treatments. Read about the problem he’s
Meeting Summary Peter Kuhn, PhD, Dean’s Professor of Biological Sciences and Professor of Medicine, Biomedical Engineering, Aerospace & Mechanical Engineering, and Urology, University of Southern
Meeting Summary “I want to use the biopsy of my tumor tissue to do a couple things: (1) to make sure that I get greater
Meeting Summary “It’s been all upside. I’m living my best life right now on this treatment. What guy wouldn’t want testosterone?” – Bryce Olson “There’s
Meeting Summary “I don’t think we know how to build these (mechanistic simulation) models (that would predict drug response or resistance for individual patients). There’s
Meeting Summary “Genes don’t reliably predict response to treatment, and the gene mutations or expression in cells don’t reliably predict the expression of proteins in
Kasey Altman was invited to speak at the Milken Global Conference in May 2022, less than two months before she passed away. She was grateful
Meeting Summary “We get the fresh sample, we process it, we use what we need for drug testing, and we freeze them down. If we
Meeting Summary “We’ve had DNA and RNA seq. Those are all great proxies for proteins. I don’t want to monkey around anymore. I want to
Meeting Summary How can physicians be convinced to overcome concerns of safety, reimbursement, and liability to prescribe novel regimens (personalized drug combinations, dosing, and sequences),
© 2021 CancerHacker Lab. All rights reserved
Recent Comments